Cited by 71Artificial Intelligence in HealthcarePancreatic and Hepatic Oncology ResearchAI in cancer detection

Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models

Open access
Hsieh, Meng Hsuen, Sun, Li-Min, Lin, Cheng-Li, Hsieh, Meng-Ju, Hsu, Chung-Y., Kao, Chia-Hung·2018·Cancer Management and Research

Abstract

Objectives: Patients with type 2 diabetes (T2DM) are suggested to have a higher risk of developing pancreatic cancer. We used two models to predict pancreatic cancer risk among patients with T2DM. Methods: The original data used for this investigation were retrieved from the National Health Insurance Research Database of Taiwan. The prediction models included the available possible risk factors for pancreatic cancer. The data were split into training and test sets: 97.5% of the data were used as the training set and 2.5% of the data were used as the test set. Logistic regression (LR) and artificial neural network (ANN) models were implemented using Python (Version 3.7.0). The F 1 , precision, and recall were compared between the LR and the ANN models. The areas under the receiver operating characteristic (ROC) curves of the prediction models were also compared. Results: The metrics used in this study indicated that the LR model more accurately predicted pancreatic cancer than the ANN model. For the LR model, the area under the ROC curve in the prediction of pancreatic cancer was 0.727, indicating a good fit. Conclusion: Using this LR model, our results suggested that we could appropriately predict pancreatic cancer risk in patients with T2DM in Taiwan. Keywords: pancreatic cancer, type 2 diabetes, logistic regression, artificial neural network

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/cmar.s180791

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Further insurance-claim models have been developed and have poor diagnostic performance (AUC 0.73).

    “Further models based on insurance claims have been developed, with poor diagnostic performance (AUC 0·73).106,107”

    From Early detection of pancreatic cancer (2020) · cites this paper as [107]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [13]Steyerberg EW Eijkemans MJ Harrell FE Habbema JD Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets Stat Med 2000 19 8 1059 1079 10790680
  2. [20]Klambauer G Unterthiner T Mayt A Self-normalizing neural networks Advances in Neural Information Processing Systems 2017 971 980

Cited by

Sorted by citations

Authors
Hsieh, M. H., Sun, L.-M., Lin, C.-L., Hsieh, M.-J., Hsu, C.-Y., & Kao, C.-H.
Affiliations
  • Poznan University of Medical Sciences (PL)
  • Zuoying Armed Forces General Hospital (TW)
  • China Medical University (TW)
  • Asia University (TW)
Corresponding author
Kao, Chia-Hung
Venue
Cancer Management and Research
Published
2018-11
Volume
Volume 10
Pages
6317-6324
ISSN
1179-1322 (ISSN-L)
OpenAlex
W2902936037
Cited by
71
References
35
Citations by year
2026: 4 · 2025: 14 · 2024: 7 · 2023: 15 · 2022: 10 · 2021: 10 · 2020: 9 · 2019: 2
FWCI
6.62
Type
journal article
Language
en
Open access
Locations
  • Cancer Management and Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • Ministry of Health and Welfare (MOHW107-TDU-B-212-123004, BM10701010021, DMR-107-192)
  • Academia Sinica (DMR-107-192, BM10701010021, MOHW107-TDU-B-212-123004)
  • China Medical University Hospital ((BM10701010021), MOHW107‐TDU‐B‐212‐123004, DMR-107–192)
  • China Medical University (BM10701010021, MOHW107-TDU-B-212-123004)
  • Division of Materials Research
Topics
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
Keywords
pancreatic cancer, type 2 diabetes, cancer risk prediction, risk factors, logistic regression, artificial neural networks, forecasting model comparison, Taiwan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review